Global Onychomycosis (Tinea Unguium) Drug Market Survey and Trend Research 2018

December 2017 | 84 pages | ID: G74A4F215EAEN
99Strategy

Abstracts

SUMMARY

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.And main types of medicine are Itraconazole, Terbinafine,Fluconazole, Amorolfine, Ciclopirox.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Pfizer, Yangtze River, Torrent Pharma, J&J, Novartis, Novartis, Qilu Pharmaceutical, Hubei Hengan, Xiuzheng Pharmaceutical, Valeant Pharma, TARO, Perrigo, Galderma, Zhejiang Deyer, Moberg etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Onychomycosis (Tinea Unguium) Drug Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Pfizer (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Yangtze River (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Torrent Pharma (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 J&J (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Novartis (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Novartis (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Qilu Pharmaceutical (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Hubei Hengan (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Xiuzheng Pharmaceutical (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Valeant Pharma (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 TARO (Company Overview, Sales Data etc.)
4.12 Perrigo (Company Overview, Sales Data etc.)
4.13 Galderma (Company Overview, Sales Data etc.)
4.14 Zhejiang Deyer (Company Overview, Sales Data etc.)
4.15 Moberg (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Onychomycosis (Tinea Unguium) Drug Market 2012-2017, by Type, in USD Million
Table Global Onychomycosis (Tinea Unguium) Drug Market 2012-2017, by Type, in Volume
Table Global Onychomycosis (Tinea Unguium) Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Onychomycosis (Tinea Unguium) Drug Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Yangtze River Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Yangtze River (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Torrent Pharma Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Torrent Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table J&J Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of J&J (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Qilu Pharmaceutical Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Qilu Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hubei Hengan Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Hubei Hengan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Xiuzheng Pharmaceutical Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Xiuzheng Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharma Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Valeant Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TARO Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of TARO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Perrigo Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Perrigo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galderma Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Galderma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zhejiang Deyer Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Zhejiang Deyer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Moberg Overview List
Table Onychomycosis (Tinea Unguium) Drug Business Operation of Moberg (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Onychomycosis (Tinea Unguium) Drug Sales Revenue Share, by Companies, in USD Million
Table Global Onychomycosis (Tinea Unguium) Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Onychomycosis (Tinea Unguium) Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Onychomycosis (Tinea Unguium) Drug Demand 2012-2017, by Application, in USD Million
Table Onychomycosis (Tinea Unguium) Drug Demand 2012-2017, by Application, in Volume
Table Onychomycosis (Tinea Unguium) Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Onychomycosis (Tinea Unguium) Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Onychomycosis (Tinea Unguium) Drug Market 2012-2017, by Region, in USD Million
Table Global Onychomycosis (Tinea Unguium) Drug Market 2012-2017, by Region, in Volume
Table Onychomycosis (Tinea Unguium) Drug Market Forecast 2018-2023, by Region, in USD Million
Table Onychomycosis (Tinea Unguium) Drug Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Onychomycosis (Tinea Unguium) Drug Industry Chain Structure
Figure Global Onychomycosis (Tinea Unguium) Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Onychomycosis (Tinea Unguium) Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Onychomycosis (Tinea Unguium) Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Onychomycosis (Tinea Unguium) Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region